Get started
Author

Evangelia Kataxaki

Observed name: Ευαγγελία Καταξάκη
ORCID: 0000-0002-2089-4174
Observed ORCID: 0000-0002-2089-4174
OpenAlex ID: A5112501998
Better outcomes of COVID-19 in vaccinated compared to unvaccinated patients with systemic rheumatic diseases
2021 · Charalampos Papagoras, George E Fragoulis, et al. · Annals of the Rheumatic Diseases · 62
The impact of upper limb exercise on function, daily activities and quality of life in systemic lupus erythematosus: a pilot randomised controlled trial
2020 · Kyriaki Keramiotou, Christos Anagnostou, et al. · RMD Open · 46
PDF
Identification and characteristics of patients with potential difficult-to-treat psoriatic arthritis: exploratory analyses of the Greek PsA registry
2024 · Konstantinos D Vassilakis, Charalampos Papagoras, et al. · Rheumatology · 39
Disease Profile and Achievement of Therapeutic Goals in a Modern, Nationwide Cohort of 923 Patients with Psoriatic Arthritis
2023 · George E. Fragoulis, Charalampos Papagoras, et al. · Mediterranean Journal of Rheumatology · 18
PDF
SLICC-Frailty Index is independently associated with impaired physical function, activities of daily living and quality of life measures
2022 · Kyriaki Keramiotou, Christos Anagnostou, et al. · Rheumatology · 18
Impaired hand function and performance in activities of daily living in systemic lupus erythematosus, even in patients achieving lupus low disease activity state (LLDAS)
2021 · Kyriaki Keramiotou, Christos Anagnostou, et al. · Rheumatology Advances in Practice · 17
PDF
Identification and characteristics of patients with axial psoriatic arthritis: clinical, phenotypic and imaging associations
2025 · Konstantinos D Vassilakis, Charalampos Papagoras, et al. · Rheumatology · 10
Omicron variant dominance and anti-SARS-CoV-2 vaccination are key determinants for a milder course of COVID-19 in patients with systemic autoimmune rheumatic diseases
2023 · Charalampos Papagoras, Nikoleta Zioga, et al. · Clinical Rheumatology · 10
PDF
Apremilast for biologic-naïve, peripheral psoriatic arthritis, including patients with early disease: results from the APROACH observational prospective study
2023 · Petros P. Sfikakis, Dimitrios Vassilopoulos, et al. · Rheumatology International · 10
PDF
Disease characteristics, co-morbidities and treatment response in a contemporary axial spondyloarthritis cohort: Analysis of 717 patients from the Greek AxSpA registry
2025 · Charalampos Papagoras, George E. Fragoulis, et al. · Seminars in Arthritis and Rheumatism · 6
Systemic Lupus Erythematosus and Myasthenia Gravis in a Male Patient: an HLA Case Investigated
2021 · Eleni Klimi, Evangelia Kataxaki · Mediterranean Journal of Rheumatology · 5
PDF
Disease-related and psychosocial factors associated with difficult-to-manage and treatment-refractory axial spondyloarthritis: insights from the Greek AxSpA Registry
2026 · N. Kougkas, Konstantinos Tsafis, et al. · Rheumatology International · 2
CRP at diagnosis in psoriatic arthritis: what it means and associations with long-term outcomes
2026 · Angeliki E Dimopoulou, Charalampos Papagoras, et al. · Rheumatology · 1
PDF
Monosodium Iodoacetate (MIA) induced experimental osteoarthritis animal model
2014 · Efstathios Chronopoulos, Angelos Kaspiris, et al.
Αναλγητική δράση της καλσιτονίνης σολομού σε πρόσφατα σπονδυλικά οστεοπορωτικά κατάγματα
2003 · Ευαγγελία Καταξάκη
Works count: 15
Citation count: 244
H-index: 9
I10-index: 9
Year
Topic
Type